Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php |
Title | Innovative Cellular Therapeutics - Next Generation |
Description | Next Generation CAR-T Innovative cellular therapies to transform cancer treatment worldwide. Discover |
Keywords | N/A |
WebSite | ictbio.com |
Host IP | 160.153.96.65 |
Location | United States |
Site | Rank |
US$4,051,283
Last updated: 2022-06-21 17:16:14
ictbio.com has Semrush global rank of 2,612,581. ictbio.com has an estimated worth of US$ 4,051,283, based on its estimated Ads revenue. ictbio.com receives approximately 467,456 unique visitors each day. Its web server is located in United States, with IP address 160.153.96.65. According to SiteAdvisor, ictbio.com is safe to visit. |
Purchase/Sale Value | US$4,051,283 |
Daily Ads Revenue | US$3,740 |
Monthly Ads Revenue | US$112,190 |
Yearly Ads Revenue | US$1,346,273 |
Daily Unique Visitors | 31,164 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
ictbio.com. | A | 10800 | IP: 160.153.96.65 |
ictbio.com. | NS | 3600 | NS Record: ns69.domaincontrol.com. |
ictbio.com. | NS | 3600 | NS Record: ns70.domaincontrol.com. |
ictbio.com. | MX | 3600 | MX Record: 5 qiye163mx01.mxmail.netease.com. |
ictbio.com. | MX | 3600 | MX Record: 10 qiye163mx02.mxmail.netease.com. |
ictbio.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.163.com -all |
Company About Team Technology Pipeline Publications News Careers Contact Us Innovative Cellular Therapeutics Innovative cellular therapies to transform cancer treatment worldwide Discover More Next Generation CAR-T Technology CAR-T cell therapies for blood cancers and solid tumors are being developed by our own significant internal R&D team, based on our comprehensive experience in gene editing, cell therapy and immunotherapy. Advanced, Clinical Stage CAR-T Platform IND cleared by U.S. FDA for ICTCAR014 — IRB-approved human trials in China demonstrated 92.3% ORR (53.8% CR; 38.5% PR), significant tumor shrinkage and limited toxicity. IND cleared by China FDA for ICTCAR003. CoupledCAR TM for Solid Tumors IRB-approved human trials being conducted in China with in-house developed CoupledCAR TM technology in a range of solid tumor indications. Better CAR-T Therapy for Both Liquid and Solid Tumors Discover our broad pipeline of next generation CAR-T immunotherapies. Pipeline Overview ICT |
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 18:33:30 GMT Server: Apache X-Powered-By: PHP/7.2.34 X-Redirect-By: WordPress Upgrade: h2,h2c Connection: Upgrade Location: https://www.ictbio.com/ Referrer-Policy: no-referrer-when-downgrade Content-Type: text/html; charset=UTF-8 HTTP/2 200 last-modified: Thu, 07 Oct 2021 11:34:36 GMT etag: "15760-5cdc1a5bcc5e9" accept-ranges: bytes content-length: 87904 vary: Accept-Encoding referrer-policy: no-referrer-when-downgrade pragma: public cache-control: max-age=3600, public content-type: text/html; charset=UTF-8 date: Sat, 23 Oct 2021 18:33:31 GMT server: Apache |
Domain Name: ICTBIO.COM Registry Domain ID: 2015616289_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-11-30T03:21:49Z Creation Date: 2016-03-25T10:57:04Z Registry Expiry Date: 2023-03-25T10:57:04Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS69.DOMAINCONTROL.COM Name Server: NS70.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T04:39:13Z <<< |